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ABSTRACT:  Nanoscience is at the leading edge of the rapidly developing field of 
nanotechnology. Nanosciences and nanotechnology are transforming a wide array of 
products and services that have the potential to enhance the practice of medicine and 
improve public health. Several areas of medical care are already benefiting from the 
advantages that nanotechnology can offer. Applications of nanoscience are in 
biotechnology, medicine, pharmaceuticals, physics, material science and also electronics. 
Nanotechnology extends the limits of molecular diagnostics to the nanoscale. 
Nanotechnology on a chip is one more dimension of microfluidic/lab on a chip technology. 
We still suffer serious and complex illnesses like cancer, cardiovascular diseases, multiple 
sclerosis, Alzheimer’s and Parkinson’s disease, and diabetes as well as different kinds of 
serious inflammatory or infectious diseases (e.g. HIV). It is of extreme importance to face 
these diseases with appropriate means. The interplay between nanoscience and 
biomedicine is the hallmark of current scientific research worldwide. The use of 
nanoscience may open new vistas of improving the effectiveness and efficiency of medical 
diagnosis and therapeutics, so called nanomedicine. An appealing example is the use of 
quantum dots as fluorescent labels. Despite recent progress in the treatment of cancer, the 
majority of cases are still diagnosed only after tumors metastasize, leaving the patient with 
a grim prognosis. Nanotechnology is in a unique position to transform cancer diagnostics 
and to produce a new generation of biosensors and medical imaging techniques with higher 
sensitivity and precision of recognition. Novel nanotechnologies can complement and 
augment existing genomic and proteomic techniques employed to analyze variations across 
different tumor types, thus offering the potential to distinguish between normal and 
malignant cells. This brief review tries to reiterate the most contemporary developments in 
the field of applied nanoscience, particularly in their relevance in diagnosis of various 
diseases and discuss their future prospects. 
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INTRODUCTION
ᴪ 
 
Nanoscience is the study of phenomena and 
manipulation of materials at atomic, molecular and 
macromolecular scales, where properties differ 
significantly from those at a larger scale; and 
nanotechnology is the design, characterization, 
production and application of structures, devices 
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and systems by controlling shape and size at the 
nanometre scale.
1 The prefix ‘nano’ is derived from 
the Greek word for dwarf. One nanometre (nm) is 
equal to one-billionth of a metre. A human hair is 
approximately 80,000nm wide, and a red blood cell 
approximately 7000nm wide. Nanobiotechnology 
is another chief field of investigation. The thrust is 
to combine nanoscale engineering with biology to 
manipulate living systems directly or build 
biologically inspired materials and devices at the 
molecular level. The origin of nanoscience and 
nanotechnologies is often attributed to a concept Menezes et al / Nanoscience in diagnostics 
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advanced by Nobel Laureate Richard P. Feynman, 
who in a 1959 lecture at the California Institute of 
Technology, stated “There is plenty of room at the 
bottom. Many of the cells are very tiny, but they 
are active: they manufacture substance; they walk 
around; they wiggle: and they do all kinds of 
marvelous things all on a very small scale. Also 
they store information. Consider the possibility that 
we too can make things very small which does 
what we want when we want-and that we can 
manufacture an object that maneuvers at that 
level.” 
2, 3 The term ‘nanotechnology’ was not used 
until 1974, when Norio Taniguchi, a researcher at 
the University of Tokyo, Japan used it to refer to 
the ability to engineer materials precisely at the 
nanometre level.
4  The primary driving force for 
miniaturisation at that time came from the 
electronics industry, which aimed to develop tools 
to create smaller (and therefore faster and more 
complex) electronic devices on silicon chips. 
Because of the small dimensions, most of the 
applications of nanobiotechnology in molecular 
diagnostics fall under the broad category of 
biochips/microarrays but are more correctly termed 
nanochips and nanoarrays. Microarray/biochip 
methods employing the detection of specific 
biomolecular interactions are now an indispensable 
tool for molecular diagnostics, but there are some 
limitations. DNA microarrays and ELISA rely on 
the labeling of samples with a fluorescent or 
radioactive tag – a highly sensitive procedure that 
is time consuming and expensive. The chemical 
modification and global amplification of the 
nucleic acid samples are achieved by PCR which 
can introduce artefacts caused by the preferential 
amplification of certain sequences. Alternative 
label-free methods include surface plasmon 
resonance and quartz crystal microbalance.     
Nanotechnologies also provide label-free detection. 
Nanotechnology is thus being applied to overcome 
some of the limitations of biochip technology.
5 
Applications of nanotechnologies in medicine are 
especially promising, and areas such as disease 
diagnosis, drug delivery targeted at specific sites in 
the body and molecular imaging are being 
intensively investigated and some products are 
undergoing clinical trials. Nanocrystalline silver, 
which is known to have antimicrobial properties,
 is 
being used in wound dressings in the USA.
6 
Applications of nanoscience and nanotechnologies 
are also leading to the production of materials and 
devices such as scaffolds for cell and tissue 
engineering, and sensors that can be used for 
monitoring aspects of human health. The interplay 
between nanoscience and biomedicine is the 
hallmark of current scientific research worldwide. 
The use of nanoscience may open new vistas of 
improving the effectiveness and efficiency of 
medical diagnosis and therapeutics. Applications of 
nanotechnology for the treatment, diagnosis, 
monitoring, and control of biological systems has 
recently been referred to as ‘Nanomedicine’ by the 
National Institutes of Health (NIH).  An appealing 
example is the use of quantum dots as fluorescent 
labels. On the other hand, the language of 
biomedicine can be translated to allow formation of 
nanostructures with biomimetic structural and 
functional complexity. For instance, DNA is 
extensively used to direct the organization of 
nanoparticles. The gap between nanoscience and 
biomedicine has to be bridged to establish a 
common understanding of how nanoscience and 
biomedicine can augment each other and what 
impact can be envisioned from this cooperation. 
Nanostructures display unique mechanical, 
electrical, chemical, and optical properties. 
Understanding and controlling such properties is 
challenging, but harnessing them will provide 
exciting new opportunities for research, diagnosis, 
and therapy.
7 Sensitive biosensors constructed out 
of nanoscale components (e.g., nanocantilevers, 
nanowires and nanochannels) can recognize genetic 
and molecular events and have reporting 
capabilities, thereby offering the potential to detect 
rare molecular signals associated with malignancy. 
Such signals may then be collected for analysis by 
nanoscale harvesters that selectively isolate cancer-
related molecules from tissues. Another area with 
near-term potential for the early detection of cancer 
is the identification of mutations and genomic 
instability.
8 
A large subject area, nanomedicine includes, for 
example, nanoparticles that act as biological 
mimetics, nanofibers and polymeric nanoconstructs 
as biomaterials, sensors and laboratory 
diagnostics.
9 It has become increasingly clear that 
progress forward in nanoscience and 
nanotechnology requires a particularly wide 
spectrum of skills and knowledge. As such, a 
number of interdisciplinary research programs and 
other efforts have been established to promote 
collaboration among relevant fields. An example is 
the National Cancer Institute's Nanobiology Think 
Tank, an outreach program to promote 
collaborations, disseminate knowledge and enhance 
the development of novel creative ideas for 
research and biomedical application. With similar 
objectives, a number of academic institutions have 
established special institutes and centers dedicated 
to nanotechnology.
3 
Nanotechnology research has emerged a bench-top 
tool for rapid diagnosis of infectious disease and 
detection of tiny genetic mutations known as 
single-nucleotide polymorphisms (SNPs). This 
could well expedite a physician's determination of 
the status of an infectious patient and have broader 
benefits for public health as infectious diseases 
continue to be a growing threat to all nations. Other 
nanomedicine projects are aimed at rational 
delivery and targeting of pharmaceutical, Menezes et al / Nanoscience in diagnostics 
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therapeutic and diagnostic agents via intravenous 
and interstitial routes of administration with 
nanosized particles. The promising application of 
nanoscience and nanotechnology may well 
contribute important tools for promoting health, 
preventing disease and otherwise improve the 
quality of life for all segments of the population.
10 
 
NANOSCIENCE IN HEALTHCARE 
 
Healthcare has been evolving from reactive 
medicine (disease is detected and treated in late 
stages) to a personalized, proactive and 
preventative medicine (presymptomatic disease is 
detected and treated on an individual basis). At the 
heart of this transformation will be a host of new, 
miniaturized technologies that permit biological 
information to be acquired and analysed quickly 
and cheaply. As genomic sequencing becomes 
more affordable, patients will have at least some 
information relevant to their probabilistic future 
health, which can be used to schedule physician 
visits before the development of symptoms. Given 
advances in the knowledge of disease biomarkers 
such as proteins, circulating tumour cells
11 and 
microRNAs
12 it is likely that, for a given disease, a 
panel of blood-based biomarkers will be assessed 
to provide pre-symptomatic information relevant to 
the onset and progression of the disease. 
Nanotechnology is already starting to have an 
impact on the diagnosis, treatment and prevention 
of disease, especially by enabling early disease 
detection and diagnosis, as well as precise and 
effective therapy. It approaches in surgery, cancer 
diagnosis & therapy, bio-detection of molecular 
disease markers, molecular imaging, implant 
technology, tissue engineering, and devices for 
drug, protein, gene and radionuclide delivery. 
While many of these medical nanotechnology 
applications are still in their infancy. Nanoparticles 
or nanostructures are utilized as novel drug 
delivery systems.
13,14 Systemic administration of 
chemotherapeutic agents, in addition to its anti-
tumor benefits, results in indiscriminate drug 
distribution and severe toxicity. This shortcoming 
may be overcome by targeted drug-carrying 
platforms that ferry the drug to the tumor site while 
limiting exposure to non-target tissues and 
organs.
15 
The rapid and sensitive detection of pathogenic 
bacteria is extremely important in medical 
diagnosis and measures against bioterrorism. 
Recent advances in the field of nanotechnology led 
several groups to recognize the promise of 
recruiting nanomaterials to the ongoing battle 
against pathogenic bacteria.
16 Rapid, selective, and 
sensitive detection of viruses is crucial for 
implementing an effective response to viral 
infection, such as through medication or 
quarantine. Direct, real-time electrical detection of 
single virus particles can be achieved with high 
selectivity by using nanowire field effect 
transistors.
17 
Sensor, able to detect the presence of a single 
molecule in samples like blood represents one of 
the greatest challenges for nanotechnologies. Not 
only does it require precision in manufacture, but it 
also requires a unique mixture of electronics, 
optics, chemistry, biochemistry and medicine to 
make devices that can be used routinely, cheaply 
and reliably to monitor the state of human health. 
An example of this is in point-of-care health 
screening where a single drop of blood placed on a 
sensor chip would be almost instantaneously 
analysed to provide data to aid a diagnosis. This 
will require the processing power of a silicon chip 
with biochemical sensitivity to identify many blood 
components. This type of monitoring could also 
begin to be incorporated within the body to provide 
constant monitoring of health, such as in the 
control of diabetes or in critical care. There are 
many other potential applications of such devices 
in medicine, making this an area of increasing 
investment. 
 
NANOSCIENCE IN DIAGNOSTICS 
 
The enormous increase in knowledge of the human 
genome (genomics) and of expression products, 
proteins (proteomics), makes it possible in an 
increasing number of cases to trace diseases to 
abnormalities at the molecular level. In theory, this 
gives rise to the possibility of making a diagnosis at 
a very early stage and of possibly starting treatment 
even before the initial symptoms of the disease 
appear.
18 Attention in medicine is, therefore, 
increasingly focusing on prevention. Neonatal 
screening (by means of a heel prick) for metabolic 
diseases is a good example of this.
19 The medical 
profession has an ever increasing number of 
technical tools at its disposal for detecting these 
molecular biomarkers. The diagnostic research can 
be conducted in the laboratory using samples taken 
from the human body (in vitro research) but it can 
also be carried out directly on the patient (in vivo). 
This distinction is important because, in the latter 
case, the tools/agents have to meet more stringent 
requirements. 
Research into DNA can be conducted to measure 
gene expression in diseased tissue, or to ascertain 
which variant of a particular gene a person has. 
Many human genes exist in several forms, which 
only differ in a single base pair. These are known 
as SNPs. The corresponding protein variants may 
differ from each other in a single amino acid and 
then display a considerable difference in 
functionality. SNPs are the root of all kinds of 
genetic disorders and also affect a person’s 
sensitivity to chemical substances, including 
medicines. This refers to their therapeutic effect as Menezes et al / Nanoscience in diagnostics 
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well as their side effects.
20 Genetic research offers 
major possibilities for identifying gene types that 
predispose a person to certain diseases and for 
achieving better matches between individual 
patients and the medicines they are prescribed.
21, 22 
DNA chips used for analyzing DNA have been 
available for a few years now. They are currently 
widely used in scientific, biomedical research but 
they are rarely used in clinical practice. DNA chips 
and other biochips were originally an achievement 
of microtechnology but miniaturisation is 
advancing here too, as with computer chips. 
Nanotechnologies are also increasingly playing a 
role in producing the chips and in increasing their 
detection sensitivity and reliability.
23-26 A new 
nanotechnological analytical method uses quantum 
dots.
27 DNA in a sample is identified on the basis 
of its bonding to DNA molecules of a known 
composition embedded in micrometre-sized 
polymer spheres containing various mixtures of 
quantum dots, each of which provides a unique 
spectral bar code (colour code).
28 American 
researchers have used this method to study SNPs in 
genes that code for enzymes of the cytochrome 
P450 family which are involved in the breakdown 
of substances (including medicines) in the body.
29 
The method is very suitable for studying large 
quantities of samples on many SNPs 
simultaneously (multiplex analyses). 
Antibodies placed on nanowires can be used in a 
similar way to detect viruses, for example in a 
blood sample.
17, 30 The bonding of a single virus 
particle to an antibody results in a change in the 
nanowire’s electric conductance. The method is 
extremely sensitive which means that an infection 
can be detected at a very early stage. It is also 
suitable for multiplex analyses. Work is also 
underway on sensors based on carbon nanotubes, 
for use in microarrays.
31 Detection methods based 
on cantilevers, nanowires or nanotubes offer the 
added advantage that it is not necessary to label the 
sample. Labs-on-a-chip  are pocket-sized 
laboratories. They can be used for analyzing 
biopolymers and also for research and for 
manipulating cells. They are expected to play an 
important role in the further development of 
biosensors for the detection of pathogenic 
bacteria.
32 In due course, there will also be 
possibilities for point-of-care applications, in which 
simple analyses can be made in the general 
practitioner’s clinics, in the patients’ homes and 
carried out by the patients’ themselves.
33 
Multiple nanoparticle detection methods have been 
developed, including scanning and transmission 
electron microscopy
34  Raman spectroscopy
35  and 
the naked eye.
36 Detection by the naked eye may be 
preferable, as other techniques are expensive and 
require specialized equipment and additional 
preparations. Both a DNA microarray and a 
heterogeneous immunoassay have been developed 
with 10-nm gold particles amplified with silver, 
which can be detected by the naked eye
36  Most 
recently, the light-scattering properties of 
submicroscopic metal particles, such as gold 
nanoparticles, have been investigated.
37  These 
particles scatter incident white light to generate 
monochromatic light and can be seen either by the 
naked eye or by dark-field microscopy. The 
intensity generated by a nanoparticle is 100,000 
times that generated by a fluorescein-labeled 
molecule. The approach has been used with success 
in DNA hybridization arrays, 
immunohistochemistry, and immunoassays
38  The 
resonance light-scattering (RLS) properties of 
nanoparticles render them well suited for use in 
microchannel-based immunoassays.
5 
Long-term stability and biocompatibility with a 
variety of macromolecules, such as DNA, RNA, 
and proteins, indicate that the metal nanoparticles 
can be used successfully as a label for a variety of 
diagnostic approaches. The immunoassay proved to 
be capable of detecting H. pylori and Escherichia 
coli O157:H7 antigens at quantities as low as 10 
ng. This detection limit is comparable to that of the 
conventional dot blot ELISA.
39  A monoclonal 
antibody raised against a specific bacterial 
antigenic epitope could be used in the future to 
potentially further improve the sensitivity of 
detection.
40 
In the case of in vivo diagnostics, patients are given 
contrast agents or radiopharmaceuticals. Their 
specific properties mean that these agents are 
useful in imaging pathophysiological changes and 
functional changes such as changes in blood flow 
in cells, tissue, and organs. The term molecular 
imaging is often used, as today’s imaging 
techniques are increasingly concerned with making 
molecular biomarkers of disease processes visible, 
for instance, a receptor protein on the surface of a 
cancer cell. Besides being given a contrast agent 
(the imaging component), a carrier molecule or 
particle is also given a molecule that specifically 
binds to the biomarker, such as an antibody (the 
targeting component). Imaging that focuses on 
molecular biomarkers makes early detection of 
diseases possible and provides information on 
appropriate therapies. Imaging is also very suitable 
for monitoring, evaluating and optimizing 
treatment, which is, being provided.
18 
 
NANOSCIENCE AND CANCER DIAGNOSIS 
 
Cancer is a major public health problem in the 
world, and one in four deaths in the United States is 
due to cancer, with an estimated 1479350 new 
cancer cases and 562340 deaths from cancer 
expected in 2009.
41 Nanotechnology is an emerging 
field that may have  potentials to make paradigm 
changes in the detection, treatment, and prevention 
of cancer.
42 Nanoscience raises new promises in the Menezes et al / Nanoscience in diagnostics 
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diagnosis and treatment of various cancers. They 
can also facilitate important advances in detection, 
diagnosis, and treatment of human cancers and 
have led to a new discipline of nano-oncology.
43 
Nanoparticles offer a new method of tumor 
targeting, already available in clinical practice, 
which can concomitantly improve the efficacy and 
decrease the toxicity of existing or novel anticancer 
agents. This makes them an ideal candidate for 
precisely targeting cancer cells. Molecular imaging 
is now considered as a high area in cancer 
diagnosis.
44 
In the near future, the use of nanotechnology could 
revolutionize not only oncology, but also the entire 
discipline of medicine. The development of 
resistance to variety of chemotherapeutic agents is 
one of the major challenges in effective cancer 
treatment. Nanotechnology could enhance the 
precision of drugs that have one highly specialized 
mission, like finding and killing cancer cells or 
tumors. Additionally, multifunctional nanocarriers 
are developed to enhance drug delivery and 
overcome multidrug resistance (MDR) by either 
simultaneous or sequential delivery of resistance 
modulators (e.g., with P-glycoprotein substrates), 
agents that regulate intracellular pH, agents that 
lower the apoptotic threshold (e.g., with ceramide), 
or in combination with energy delivery (e.g., 
sound, heat, and light) to enhance the effectiveness 
of anticancer agents in refractory tumors.
45 
Nanoparticle (NP) has large surface area which can 
be conjugated or coated with different molecular 
probes for diverse detection system (optical, 
electrical, magnetic etc.) as well as used as a 
vehicle to carry different biomolecules and 
anticancer drugs to tumor cells. The nanoparticles 
that can be used to replace conventional contrast 
agents include liposomes, dendrimers, and 
nanotubes. Surface or hollow cores of these 
nanoparticles can be loaded with imaging agents, 
such as paramagnetic or superparamagnetic metals 
or radionuclides. Semiconductor quantum dot (QD) 
with novel optical and electronic properties helped 
to devise a new class of NP probes for molecular, 
cellular, and in vivo imaging. A large variety of 
materials ranging from metal, ceramic, polymer, 
lipid, protein and nucleic acid are used for 
developing novel nanoparticles with multiple 
functions which can detect different aspects of 
cancer biology and progression. The major issue of 
concern is biocompatibility and safety of these 
materials and their fate after in-vivo use. However 
with collaborative interdisciplinary research it will 
be possible to develop safer nanomaterials in 
future. Optically efficient, cancer specific Quantum 
dots provide a new tool to enable noninvasive 
visualization of disease-specific molecular and 
tissue changes with subcellular spatial resolution.
46 
Nanotechnology is in a unique position to 
transform cancer diagnostics and to produce a new 
generation of fluorescent markers and medical 
imaging techniques with higher sensitivity and 
precision of recognition.
47 
Nanotechnology offers a wide range of tools, from 
chip-based nanolabs, capable of monitoring and 
manipulating individual cells, to nanoscale probes 
that can track the movements of cells and even 
individual molecules as they move about in their 
environment.
48  As such, nanotechnology can 
complement other technology platforms, such as 
proteomics and bioinformatics. Another near-term 
application of nanotechnology to accelerate basic 
research is to use molecular-size nanoparticles with 
a wide range of optical properties (e.g., quantum 
dots) to track individual molecules or cells as they 
move through local environments, thereby 
monitoring multiplexed cellular and molecular 
events in real time.
5, 49 
In the USA the National Nanotechnology Initiative 
has claimed that nanotechnology has potential in 
the treatment of cancer. It has been stated that ‘It is 
conceivable that by 2015, our ability to detect and 
treat tumors in their first year of occurrence might 
totally eliminate suffering and death from cancer’.
50 
Although it is reasonable to hope that some 
measures based on nanotechnologies may make 
contributions to detection and treatment of some 
forms of cancer, other factors such as a greater 
understanding of environmental causes of cancer, 
public health measures, and advances in surgical, 
pharmacological and radiological management are 
important in the reduction of incidence of and death 
from cancer. In the more distant future we will 
likely see nanotherapeutics with release 
mechanisms that are customized for precisely 
controlled release rates, dependent upon the 
mechanism of the therapeutic to be delivered. It is 
also likely that nanotherapeutics will appear that 
have their size, shape and elastic modulus 
optimized to permit passage across the blood/brain 
barrier.
51 
 
BRIEF SUMMARY OF NANOTECHNOLOGY 
BASED DIAGNOSTICS IN USE 
 
Various nanotechnologies with potential 
applications in molecular diagnostics are 
nanotechnology on a chip (nanoChip
TM, 
nanoArrays
TM), Nanoparticle technologies (Gold 
particles, Nanobarcodes, Quantum dot technology, 
Nanoparticle probes) and other technologies 
(Nanowires, Nanopore technology, Cantilever 
arrays, DNA nanomachines for molecular 
diagnostics, Nanosensors, Resonance light 
scattering (RLS) technology).
5 
 
Array technologies 
 
The enormously powerful array technologies, 
which use relatively large biological samples at the Menezes et al / Nanoscience in diagnostics 
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micrometer scale, are continuously being enhanced 
for sensitivity, size and data analysis. The original 
DNA chip approach, which carries an array of 
DNA molecules on an inert carrier, is now 
routinely used in gene and protein analysis. The 
push towards higher resolution and smaller sample 
volume makes this an emerging nanotechnology. 
Lab-on-a-chip technologies, which are used for 
sensing and supporting disease diagnosis, are also 
currently in the micrometre range, but progress in 
nanofluidic systems will potentially lead to 
integrated nanoscale systems becoming available. 
These could have a range of applications, for 
example in improved devices for detection of 
biological and chemical agents in the field. 
 
Gold particles 
 
Gold nanoparticles are effective labels for sensors 
since a variety of analytical techniques can be used 
to detect them, like optical absorption, 
fluorescence, Raman scattering, atomic and 
magnetic force, and electrical conductivity. This 
technique has been used to detect life threatening 
bacteria and viruses, such as anthrax and HIV, and 
could replace PCR and the fluorescent tags 
commonly used today. Labeling oligonucleotide 
targets with gold nanoparticles rather than 
fluorophore probes substantially alters the melting-
profiles of the targets from an array substrate. A 
nanoparticle-based DNA detection system is ten-
times more sensitive and 100,000-times more 
specific than current genomic detection systems.   
Recently nanoparticles, especially gold and silver 
nano particles, have been successfully applied for 
labeling because of their controlled size 
distribution, long-term stability, and compatibility 
with biological macromolecules, including proteins 
and nucleic acids. Most recently, the light-
scattering properties of submicroscopic metal 
particles, such as gold nanoparticles, have been 
investigated. The resonance light-scattering (RLS) 
properties of nanoparticles render them well suited 
for use in microchannel-based immunoassays and 
nucleic acid studies.
40 With the advent of 
nanoscience and nanotechnology, rapid progress 
has been achieved for the effective, sensitive and 
selective detection of bio- molecules. For example 
the functionalized semiconductor nanoparticles 
(Quantum Dots) are applied to determine proteins 
and nucleic acids. 
 
Nanoparticle probes 
 
In nanoparticle probes, DNA is attached to the 
nanoparticles. The probes are then used to bind and 
signal the presence of a specific DNA sequence. 
The nanoparticle probes change color if the target 
is present in a sample. Products based on it are 
Nanosphere Spot Assay and Gold nanoparticle 
probe assays. Nanosphere Spot Assay is 
colorimetric detection of amplified DNA 
sequences. Whereas, Gold nanoparticle probe 
assays are in microarray format for analysis of 
DNA targets and eliminates the need for target 
amplification processes, such as PCR, saving both 
time and cost. Applications of nanoparticle probes 
are antibiotic resistant bacterial infection 
diagnostics, infectious disease diagnostics, 
detection of SNPs, detection of biological markers 
for cancer and blood screening. 
 
Quantum Dots 
 
Applications of quantum dot technology are DNA 
mapping, genotyping, multiplexed diagnostics and 
ultrasensitive viral RNA detection. The use of 
quantum dots in cancer investigations has increased 
intensely due to their unique size-dependent optical 
properties. Bioconjugated near-infrared quantum 
dots probes are highly sensitive molecular imaging 
tools for in vivo study. Further development of 
quantum dots might enable their application in 
detecting and localizing metastasis, quantitative 
measurement of molecular targets to facilitate 
targeted therapy, tracking drug delivery, and 
monitoring the efficacy of therapeutics 
noninvasively in real time.
52 
 
Nanowires 
 
Potential applications of nanowires are nucleic acid 
detection without amplification, quantitative PCR, 
tissue analysis, characterization of protein-protein 
interactions and integrated drug delivery & 
detection. 
 
CONCLUSION 
 
Nanodiagnostics will improve the sensitivity and 
integration of analytical methods to yield a more 
coherent evaluation of life processes. An important 
benefit would be extension of the present limits of 
molecular diagnostics. Nanoparticles are the most 
versatile material for developing diagnostics. This 
will have applications in genomic analysis, 
proteomics and molecular diagnostics. 
Nanotechnology has potential advantages in 
applications in point-of-care diagnosis, like on 
patients’ bedside, self-diagnostics for use in the 
home and for field use of sensors for lab-on-a-chip. 
Novel methods to manage the symptoms of cancer 
that adversely impact quality of life and research 
tools that will enable rapid identification, as well as 
validation of new targets for clinical development 
and prediction of drug resistance. Developing 
nanotechnologies are being pursued for general 
cellular processes such as ubiquitous signaling 
pathways that may benefit numerous physiological 
systems, as well as being targeted toward the Menezes et al / Nanoscience in diagnostics 
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particular challenges of specific disorders such as 
diabetes mellitus, cancer, Alzheimer’s, 
arteriosclerosis, and AIDS. Ethical implications in 
the use of this technology and its impact on 
medicine should be considered, as it is in only in an 
emerging stage today. Current promises offered by 
the use of this technology will touch all spheres of 
our life. We need to have a balanced view about the 
prospects of this technology in the future, so that it 
does not offer us unsubstantiated hope. 
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